Company Filing History:
Years Active: 2001-2003
Title: The Innovative Contributions of Frederique Zindy
Introduction
Frederique Zindy is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of biomedical research, particularly in understanding cell cycle regulation and its implications in cancer.
Latest Patents
Zindy holds 4 patents, with his latest innovations focusing on groundbreaking methods involving non-human animals and mammalian cells. One of his patents describes cells that lack p19ink4d and p27kip1 activity, detailing non-human animals manipulated to not express functional p19 and p27 proteins. This includes a specific example of a p19-double null, p27-double null mouse, which exhibits various health issues and a limited lifespan. Another significant patent involves ARF-P19, a novel regulator of the mammalian cell cycle, which highlights the role of the INK4A gene and its implications in tumor suppression.
Career Highlights
Frederique Zindy is affiliated with St. Jude Children's Research Hospital, where he continues to advance research in cell biology and cancer. His work has been instrumental in uncovering the complexities of cell cycle control and its relevance to cancer treatment.
Collaborations
Zindy has collaborated with esteemed colleagues, including Martine F Roussel and Charles J Sherr, contributing to a rich environment of innovation and research.
Conclusion
Frederique Zindy's contributions to science through his patents and research at St. Jude Children's Research Hospital underscore his role as a leading inventor in the field of biomedical research. His work continues to pave the way for advancements in understanding cancer and cell biology.